MUTANT DU LIGAND INDUISANT L'APOPTOSE ASSOCIEE AU FACTEUR DE NECROSE DE TUMEURS (TRAIL) DE TYPE PEPTIDE A PENETRATION MEMBRANAIRE, SON PROCEDE DE PREPARATION ET SON UTILISATION
A TRAIL mutant is provided. The mutant is a truncation of an amino acid sequence of positions 114-281 of an extracellular portion of a wild-type TRAIL protein, wherein the amino acids at positions 114-121 of said truncation are mutated into eight arginines. The TRAIL mutant may be used to treat tumors.